APL180 / Novartis - LARVOL DELTA

Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients (clinicaltrials.gov) - P2; N=0; Withdrawn; Sponsor: Novartis Pharmaceuticals; N=20 ➔ 0

Enrollment change • Biosimilar • Dyslipidemia